Skip to content
thestock.space

Bandaram Pharma Packtech (BSE: BANDARAM) is loss-making over the last 12 months, losing ₹0.54 Cr, so a P/E ratio does not apply. Its share price on 6 Nov 2026 was ₹18.53, 63% below its 52-week high. Sales grew 50% a year over 3 years. Debt is 0.86× equity. It is a small-cap company with a market cap of ₹33 Cr, ranked 59th of 83 Packaging & Containers companies by market cap; the shares fell 23% over the past year.

As of 6 Nov 2026Prices are delayed about 15 minutes; fundamentals are from the quarter ended Jun 2026.How we calculate this

past year
Open
₹18.00
Day high
₹19.05
Day low
₹18.00
Prev. close
₹18.91
Volume
20

Health check

6 to check
  • ReturnsBehind

    −22.6% over a year, better than 0 of 7 peers.

  • Price tagLoss-making

    Earnings were negative over the last 12 months.

  • GrowthUnder pressure

    Sales +49.8%, profit +3.0% a year over 3 years, but loss-making now.

  • ProfitabilityWeak

    ROCE 3.7% vs peer median 16.7%.

  • Balance sheetStretched

    Debt 0.86× equity, interest covered 1.4×, Piotroski 2 of 9.

  • Red flags4 to check

    Loss-making over the last twelve months.

Compared with 7 industry peers. Computed from reported figures. Educational, not a recommendation.

Packaging & Containers

82 listed peers. Screen the industry

Small cap

₹33 Cr, #59 of 83 in its industry by size.

Market sensitivity

Measuring against the NIFTY 50…

Key metrics

Last 12 months to Jun 2026: sales ₹87 Cr · profit ₹−1 Cr
Market cap
₹33 Cr
Small cap
P/E
61.8
Industry 18.1
Price to book
1.28
Peers 2.06
Dividend yield
0.00%
ROE
4.3%
Peers 14.4%
ROCE
3.7%
Peers 16.7%
Debt to equity
0.86
Debt ₹28 Cr
EPS (TTM)
₹0.30
OPM (TTM)
4.8%
Net margin −0.6%
Sales growth
+195.6%
Latest quarter vs a year ago
Profit growth
+2670.9%
Latest quarter vs a year ago
Price to sales
0.38
EV/EBITDA 14.8

Strengths and risks

Strengths

  • Quarterly profit up 2670.9% on a year ago.
  • Quarterly sales up 195.6% on a year ago.

Risks to check

  • Loss-making over the last twelve months.
  • Return on equity is low at 4.3%.
  • 63% below its 52-week high.
  • Interest coverage of only 2.3×.

Derived automatically from reported figures. Not a recommendation.

About Bandaram Pharma Packtech

Bandaram Pharma Packtech Limited operates in the paper industry in India. The company engages in the processing and supply of recycled wastepaper; and trading of paper board. It also supplies various categories of recycled paper to small and medium-size paper mills. The company was formerly known as Shiva Medicare Limited and changed its name to Bandaram Pharma Packtech Limited in March 2022. Bandaram Pharma Packtech Limited was incorporated in 1993 and…

Headquarters
Bengaluru
Employees
4
Sector
Consumer Cyclical
ISIN
INE875N01036

Price range

52 weeks

₹17.25₹49.70

Today

₹18.00₹19.05
Avg volume (3M)
4.5K
1-year return
minus 22.6%
From 52-week high
minus 62.7%

Peers · Packaging & Containers

Company
TIMETECHNOTime Technoplast170.65minus 1.98%8,42415.92.0615.3%13.4%10.3%12.5%28.9%0.86%minus 17.5%
EPLEPL221.31minus 3.61%7,10118.12.2616.7%14.9%19.8%8.5%19.7%2.26%plus 13.4%
AGIAGI Greenpac645.55minus 3.31%4,17711.81.6518.2%14.9%22.0%5.5%10.4%1.08%minus 18.3%
UFLEXUFLEX575.30minus 2.13%4,1546.10.517.5%4.1%14.0%1.4%−12.9%0.52%plus 9.1%
TCPLPACKTCPL Packaging4,431.10minus 2.80%4,02434.95.6118.3%14.4%12.8%7.3%−4.2%0.55%plus 37.9%
JINDALPOLYJindal Poly Films697.50minus 0.11%3,054–1.00−18.2%−29.9%−36.5%−15.6%–0.00%plus 25.0%
KNACKKnack Packaging199.71plus 1.42%2,44421.63.3438.3%35.5%17.8%16.6%67.1%0.00%plus 9.1%
BANDARAMBandaram Pharma Packtech18.53minus 2.01%3361.81.283.7%4.3%4.8%49.8%3.0%0.00%minus 22.6%
Median of 7 peers–−2.13%4,15417.02.0616.7%14.4%14.0%7.3%15.0%0.55%9.1%

Quarterly results

Consolidated, ₹ crore
SalesSelect a row below to chart it
₹ CrJun 25Sep 25Dec 25Mar 26Jun 26
8.113.714.826.324
7.513.313.825.422.4
0.60.510.81.5
7.8%3.3%6.7%3.1%6.4%
00000
0.50.30.30.50.4
0.10.10.10.20.2
00.10.50.10.9
30.4%22.4%34.1%21.7%26.0%
000.20.10.7
0.020.030.110.050.11

Profit & loss

Yearly, ₹ crore
Sales CAGR 3Y
+49.8%
Profit CAGR 3Y
+3.0%
EPS CAGR 3Y
−30.2%
ROE
4.3%
Net profitSelect a row below to chart it
₹ CrMar 2023Mar 2024Mar 2025Mar 2026
18.734.13762.9
–+81.9%+8.5%+70.2%
17.431.334.160.4
1.32.82.82.5
6.9%8.3%7.6%4.0%
−0−0.3−0.10.3
0.30.60.81.1
0.60.70.61
––−0−0.3
0.31.21.30.4
20.9%20.1%24.5%36.3%
0.30.510.3
–+102.4%+90.7%minus 71.7%
0.470.790.830.16

Forecast

Your assumptions, not a prediction

Balance sheet

At each financial year end, ₹ crore
Total assetsSelect a row below to chart it
₹ CrMar 2023Mar 2024Mar 2025Mar 2026
3121218
0.10.30.78.8
14.212.217.223.9
2.97.69.125.1
20.232.138.975.9
54.549.4
–1.41.4–
0.200.10.7
1526.133.565.7
20.232.138.975.9

Cash flow

Yearly, ₹ crore
Cash from operationsSelect a row below to chart it
₹ CrMar 2023Mar 2024Mar 2025Mar 2026
−1.1−4.1−4.9−4.9
−5.3−1.6−0.1–
4.55.65.15.5
−1.9−0.10.10.6
−2.8−0.2−0.1–
−3.9−4.3−5−4.9
––−0.2–

Shareholding pattern

This company is listed only on BSE, so there’s no NSE category split. See Major shareholders below for the named holders.

Major shareholders

BSE filing

Filings & events

News

No recent news coverage found.

My notes

Private to you